ArticleNeuro-oncology advances

Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient.

Matthew McCord et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.